These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 31931362
1. Dihydroartemisinin inhibits the proliferation of IgAN mesangial cells through the mTOR signaling pathway. Xia M, Liu D, Tang X, Liu Y, Liu H, Liu Y, Chen G, Liu H. Int Immunopharmacol; 2020 Mar; 80():106125. PubMed ID: 31931362 [Abstract] [Full Text] [Related]
2. Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro. Dai Q, Liu J, Du YL, Hao X, Ying J, Tan Y, He LQ, Wang WM, Chen N. Acta Pharmacol Sin; 2016 Feb; 37(2):228-34. PubMed ID: 26775659 [Abstract] [Full Text] [Related]
3. The Akt/mTOR/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option. Tian J, Wang Y, Guo H, Li R. Exp Mol Pathol; 2015 Dec; 99(3):435-40. PubMed ID: 26297427 [Abstract] [Full Text] [Related]
4. Rapamycin Enhances Repressed Autophagy and Attenuates Aggressive Progression in a Rat Model of IgA Nephropathy. Liu D, Liu Y, Chen G, He L, Tang C, Wang C, Yang D, Li H, Dong Z, Liu H. Am J Nephrol; 2017 Dec; 45(4):293-300. PubMed ID: 28237991 [Abstract] [Full Text] [Related]
5. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY. Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528 [Abstract] [Full Text] [Related]
6. Jixuecao (Herba Centellae Asiaticae) alleviates mesangial cell proliferation in IgA nephropathy by inducing mitofusin 2 expression. Chen H, Du Y, Li Y, Zeng J, Miao J, Jiang X. J Tradit Chin Med; 2019 Jun; 39(3):346-355. PubMed ID: 32186007 [Abstract] [Full Text] [Related]
7. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy. Tamouza H, Chemouny JM, Raskova Kafkova L, Berthelot L, Flamant M, Demion M, Mesnard L, Paubelle E, Walker F, Julian BA, Tissandié E, Tiwari MK, Camara NO, Vrtovsnik F, Benhamou M, Novak J, Monteiro RC, Moura IC. Kidney Int; 2012 Dec; 82(12):1284-96. PubMed ID: 22951891 [Abstract] [Full Text] [Related]
8. Adiponectin inhibits PDGF-induced mesangial cell proliferation: regulation of mammalian target of rapamycin-mediated survival pathway by adenosine 5-monophosphate-activated protein kinase. Su YX, Deng HC, Zhang MX, Long J, Peng ZG. Horm Metab Res; 2012 Jan; 44(1):21-7. PubMed ID: 22105511 [Abstract] [Full Text] [Related]
9. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy. Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H. BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604 [Abstract] [Full Text] [Related]
10. Rapamycin Induces Autophagy and Reduces the Apoptosis of Podocytes Under a Stimulated Condition of Immunoglobulin A Nephropathy. Liang S, Jin J, Lin B, Gong J, Li Y, He Q. Kidney Blood Press Res; 2017 Sep 29; 42(1):177-187. PubMed ID: 28427080 [Abstract] [Full Text] [Related]
11. Renoprotective effects of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via suppressing NF-κB signaling and NLRP3 inflammasome activation by exosomes in rats. Bai L, Li J, Li H, Song J, Zhou Y, Lu R, Liu B, Pang Y, Zhang P, Chen J, Liu X, Wu J, Liang C, Zhou J. Biochem Pharmacol; 2019 Nov 29; 169():113619. PubMed ID: 31465776 [Abstract] [Full Text] [Related]
12. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1. Ebefors K, Liu P, Lassén E, Elvin J, Candemark E, Levan K, Haraldsson B, Nyström J. BMC Nephrol; 2016 Apr 05; 17():40. PubMed ID: 27044423 [Abstract] [Full Text] [Related]
13. Liuwei Dihuang Pills Inhibit Podocyte Injury and Alleviate IgA Nephropathy by Directly Altering Mesangial Cell-Derived Exosome Function and Secretion. Zhu X, Shen X, Lin B, Fang J, Jin J, He Q. Front Pharmacol; 2022 Apr 05; 13():889008. PubMed ID: 35899112 [Abstract] [Full Text] [Related]
14. Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms. Tian J, Wang Y, Liu X, Zhou X, Li R. Exp Biol Med (Maywood); 2015 Jul 05; 240(7):936-45. PubMed ID: 25349217 [Abstract] [Full Text] [Related]
15. The protective effect and mechanism of rapamycin in the rat model of IgA nephropathy. Guo N, Liu S, Bow LM, Cui X, Zhang L, Xu S, Lu S, Tian J. Ren Fail; 2019 Nov 05; 41(1):334-339. PubMed ID: 31057050 [Abstract] [Full Text] [Related]
16. Triptolide promotes autophagy to inhibit mesangial cell proliferation in IgA nephropathy via the CARD9/p38 MAPK pathway. Zhao L, Lan Z, Peng L, Wan L, Liu D, Tan X, Tang C, Chen G, Liu H. Cell Prolif; 2022 Sep 05; 55(9):e13278. PubMed ID: 35733381 [Abstract] [Full Text] [Related]
17. Ursolic Acid Attenuates High Glucose-Mediated Mesangial Cell Injury by Inhibiting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Signaling Pathway. Wang EM, Fan QL, Yue Y, Xu L. Med Sci Monit; 2018 Feb 11; 24():846-854. PubMed ID: 29428962 [Abstract] [Full Text] [Related]
19. Immunosuppressive effect of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via regulating the differentiation of CD4+ T cell subsets in rats. Bai L, Li H, Li J, Song J, Zhou Y, Liu B, Lu R, Zhang P, Chen J, Chen D, Pang Y, Liu X, Wu J, Liang C, Zhou J. Int Immunopharmacol; 2019 May 11; 70():313-323. PubMed ID: 30852287 [Abstract] [Full Text] [Related]
20. Downregulation of miR‑214-3p attenuates mesangial hypercellularity by targeting PTEN‑mediated JNK/c-Jun signaling in IgA nephropathy. Li Y, Xia M, Peng L, Liu H, Chen G, Wang C, Yuan D, Liu Y, Liu H. Int J Biol Sci; 2021 May 11; 17(13):3343-3355. PubMed ID: 34512151 [Abstract] [Full Text] [Related] Page: [Next] [New Search]